23 May 2013
Keywords: genentech, extends, share, repurchase, program, biotechnology, major
Article | 20 June 2005
US biotechnology major Genentech says that its board of directors has authorized the extension of its current stock repurchase program ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 June 2005
13 June 2005
27 June 2005
© 2013 thepharmaletter.com